Envestnet Asset Management Inc Meridian Bioscience Inc Transaction History

Envestnet Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$23.75 - $31.69 $8,098 - $10,806	341 Added 0.83%	41,308 $1.26 Million
Q1 2022 May 04, 2022	BUY	$19.97 - $26.94 $41,637 - $56,169	2,085 Added 5.36%	40,967 $1.06 Million
Q4 2021 Feb 04, 2022	BUY	$17.46 - $21.61 $146,122 - $180,854	8,369 Added 27.43%	38,882 $793,000
Q3 2021 Oct 07, 2021	SELL	$17.35 - $22.5 $27,517 - $35,685	-1,586 Reduced 4.94%	30,513 $587,000
Q2 2021 Aug 04, 2021	SELL	$18.01 - $28.32 $78,001 - $122,653	-4,331 Reduced 11.89%	32,099 $712,000
Q1 2021 May 04, 2021	BUY	$19.76 - $29.89 $719,856 - $1.09 Million	36,430 New	36,430 $956,000
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $3,430 - $3,776	-231 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	231	231 $4,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.